参天製薬株式会社 - 預託証券(普通株式) - 損益計算書 (TTM)

参天製薬株式会社 - 預託証券(普通株式)
US ˙ OTCPK ˙ US80287P1003

損益計算書 (TTM)

参天製薬株式会社 - 預託証券(普通株式) 損益計算書は、一定期間における収益と費用の変化を示します。損益計算書のデータには、売上高、売上総利益、研究開発費 (R&D) 、販売費、一般管理費 (SG&A) 、営業利益、所得税、支払利息、営業外収益、1株当たり利益 (EPS) 、発行済株式数が含まれています。

1株当たりの単位を除き、すべての数値は1,000,000倍です。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
収益 257,028 259,459 263,620 266,257 266,804 266,413 270,242 279,037 285,893 295,928 302,084 301,965 304,347 302,563 301,905 300,004 293,970 291,479 287,994 291,624
変化 (%) 0.95 1.60 1.00 0.21 -0.15 1.44 3.25 2.46 3.51 2.08 -0.04 0.79 -0.59 -0.22 -0.63 -2.01 -0.85 -1.20 1.26
収益の% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
売上原価 100,404 101,383 105,028 109,671 111,153 112,705 112,416 112,950 114,568 116,504 119,101 123,256 125,237 127,308 129,298 128,977 128,391 126,149 123,949 121,881
変化 (%) 0.98 3.60 4.42 1.35 1.40 -0.26 0.48 1.43 1.69 2.23 3.49 1.61 1.65 1.56 -0.25 -0.45 -1.75 -1.74 -1.67
収益の% 39.06 39.07 39.84 41.19 41.66 42.30 41.60 40.48 40.07 39.37 39.43 40.82 41.15 42.08 42.83 42.99 43.67 43.28 43.04 41.79
営業総利益 156,624 158,076 158,592 156,586 155,651 153,708 157,826 166,087 171,325 179,424 182,983 178,709 179,110 175,255 172,607 171,027 165,579 165,330 164,045 169,743
変化 (%) 0.93 0.33 -1.26 -0.60 -1.25 2.68 5.23 3.15 4.73 1.98 -2.34 0.22 -2.15 -1.51 -0.92 -3.19 -0.15 -0.78 3.47
収益の% 60.94 60.93 60.16 58.81 58.34 57.70 58.40 59.52 59.93 60.63 60.57 59.18 58.85 57.92 57.17 57.01 56.33 56.72 56.96 58.21
販管費 118,482 119,996 121,088 120,610 119,590 123,254 125,789 134,072 135,711 134,950 133,319 91,529 87,583 86,310 87,223 83,511 87,092 83,813 87,349 89,570
変化 (%) 1.28 0.91 -0.39 -0.85 3.06 2.06 6.58 1.22 -0.56 -1.21 -31.35 -4.31 -1.45 1.06 -4.26 4.29 -3.76 4.22 2.54
収益の% 46.10 46.25 45.93 45.30 44.82 46.26 46.55 48.05 47.47 45.60 44.13 30.31 28.78 28.53 28.89 27.84 29.63 28.75 30.33 30.71
研究開発 504 1,215 1,150 979 1,929 2,879 -798 -1,806 -3,474 25,416 24,619 23,899 23,981 24,103 24,606 25,530 25,502 26,185
変化 (%) 141.07 -5.35 97.04 49.25 126.32 92.36 -831.61 -3.14 -2.92 0.34 0.51 2.09 3.76 -0.11 2.68
収益の% 0.20 0.47 0.44 0.37 0.72 1.07 -0.28 -0.61 -1.15 8.42 8.09 7.90 7.94 8.03 8.37 8.76 8.86 8.98
運用コスト 202,380 205,832 211,001 230,382 231,751 268,364 270,893 243,737 246,177 216,509 220,479 263,425 251,756 251,604 250,682 251,709 250,271 249,142 245,690 243,826
変化 (%) 1.71 2.51 9.19 0.59 15.80 0.94 -10.02 1.00 -12.05 1.83 19.48 -4.43 -0.06 -0.37 0.41 -0.57 -0.45 -1.39 -0.76
収益の% 78.74 79.33 80.04 86.53 86.86 100.73 100.24 87.35 86.11 73.16 72.99 87.24 82.72 83.16 83.03 83.90 85.13 85.48 85.31 83.61
営業利益 54,648 53,627 52,619 35,875 35,053 -1,951 -651 35,300 39,716 79,419 81,605 38,540 52,591 50,959 51,223 48,295 43,699 42,337 42,304 47,798
変化 (%) -1.87 -1.88 -31.82 -2.29 -105.57 -66.63 -5,522.43 12.51 99.97 2.75 -52.77 36.46 -3.10 0.52 -5.72 -9.52 -3.12 -0.08 12.99
収益の% 21.26 20.67 19.96 13.47 13.14 -0.73 -0.24 12.65 13.89 26.84 27.01 12.76 17.28 16.84 16.97 16.10 14.87 14.52 14.69 16.39
支払利息 -249 -249 -95 -224 -476 -521 -754 -748 -2,664 -1,070 -1,596 -1,166 -1,083 -3,058 -1,204 -2,882 -1,994
変化 (%) -61.85 112.50 9.45 44.72 -0.80 256.15 -59.83 49.16 -26.94 -7.12 182.36 -60.63 139.37 -30.81
収益の% -0.10 -0.09 -0.04 -0.08 -0.17 -0.18 -0.25 -0.25 -0.88 -0.35 -0.53 -0.39 -0.36 -1.04 -0.41 -1.00 -0.68
純利益 7,983 7,324 5,062 27,218 26,539 -9,130 -8,195 -14,948 -11,197 26,374 27,729 26,642 26,861 26,133 27,494 36,256 31,501 31,424 30,607 37,369
変化 (%) -8.26 -30.88 437.69 -2.49 -134.40 -10.24 82.40 -25.09 -335.55 5.14 -3.92 0.82 -2.71 5.21 31.87 -13.12 -0.24 -2.60 22.09
収益の% 3.11 2.82 1.92 10.22 9.95 -3.43 -3.03 -5.36 -3.92 8.91 9.18 8.82 8.83 8.64 9.11 12.09 10.72 10.78 10.63 12.81

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista